Table Mountain Capital

Table Mountain Capital operates as a family office, specializing in alternative investments and early-stage companies. It acquires interests in emerging businesses, primarily within the life science and technology sectors. This targeted approach funds and guides innovative enterprises aligned with their specific criteria, advancing critical technological domains.

John Foskett and Robert W. Foskett established Table Mountain Capital in 2005. Meeting at Emory University in 1992, they pursued separate entrepreneurial careers. A shared interest in alternative investments and dissatisfaction with traditional wealth management led them to combine personal efforts, forming the firm. They also co-founded Kapa Biosystems, later acquired by Roche.

The firm supports early-stage life science and technology companies with essential capital. Their vision involves astute capital deployment to foster innovation across these dynamic industries. They aim to be a focused partner, contributing to specialized technology and biotechnological breakthroughs via strategic private investments.